Latest news


Capital increase registered and listing of new shares

Posted on Jan 19, 2017

Oslo, 19 January 2017, Reference is made to the previous announcements by PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) in respect of the fully underwritten rights issue of 10,000,000 new shares in the Company (the “Rights Issue”). The share capital increase pertaining to the Rights Issue, resolved by the extraordinary general meeting on […]

Final results of the rights issue

Posted on Jan 10, 2017

Oslo, 10 January, 2017 – Reference is made to the previous announcements by PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) in respect of the fully underwritten rights issue of 10,000,000 new shares in the Company (the “Rights Issue”). The subscription period for the Rights Issue expired at 16:30 CET on 5 January 2017. At […]

PCI Biotech presentation from Biotech Showcase 2017

Posted on Jan 10, 2017

Oslo, Norway, January 10, 2017 – The PCI Biotech presentation from Biotech Showcase™ 2017 is available at the link below. The presentation was held Monday, January 9, 2017 at 4:00pm PT, by Dr. Per Walday, PCI Biotech’s CEO, at the Hilton San Francisco Union Square, California, US.  170109 Biotech Showcase Presentation by PCIB